Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia

Blood (2022) 139 (21): 3111–3126.

https://doi.org/10.1182/blood.2021011846

Published: 2022

Includes: Supplemental data

Journal Articles

Loss of the Base Excision Repair Gene Apex1 Leads to Dysfunctional Adult Hematopoietic Stem and Progenitor Cells

Samantha Zaunz, Lukas Lauwereins, Manmohan Bajaj, Beatriz Guapo Neves, Francheska Cadacio, Lana Cleuren, Céline Notredame, Jurgen Marteijn, Kim De Keersmaecker, Catherine M. Verfaillie

Blood (2021) 138 (Supplement 1): 3267.

https://doi.org/10.1182/blood-2021-146369

Published: 2021

Journal Articles

14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia

Blood (2021) 138 (9): 773–784.

https://doi.org/10.1182/blood.2020010510

Published: 2021

Includes: Supplemental data

Journal Articles

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia

Llucia Albertí-Servera, Sofie Demeyer, Inge Govaerts, Toon Swings, Jolien De Bie, Olga Gielen, Marco Brociner, Lucienne Michaux, Johan Maertens, Anne Uyttebroeck, Kim De Keersmaecker, Nancy Boeckx, Heidi Segers, Jan Cools

Blood (2021) 137 (6): 801–811.

https://doi.org/10.1182/blood.2020006996

Published: 2021

Includes: Supplemental data

Journal Articles

Opportunities of Genome Imaging for Genetic Diagnosis in Acute Lymphoblastic Leukemia

Jolien De Bie, MD PhD, Barbara Dewaele, Olga Gielen, Katrina Rack, PhD, Johan A. Maertens, MD PhD, Heidi Segers, MD PhD, Joris Vermeesch, PhD, Kim De Keersmaecker, PhD, Jan Cools, PhD, Lucienne Michaux, MD PhD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-139541

Published: 2020

Journal Articles

Evolution of Clinically Relevant Subclones during Chemotherapy Treatment of ALL As Determined By Single-Cell DNA and RNA Sequencing

Llucia Albertí Servera, PhD, Sofie Demeyer, PhD, Inge Govaerts, MD PhD, Olga Gielen, Heidi Segers, MD PhD, Anne Uyttebroeck, MD, Nancy Boeckx, Johan A. Maertens, MD PhD, Kim De Keersmaecker, PhD, Jan Cools, PhD

Blood (2019) 134 (Supplement_1): 2749.

https://doi.org/10.1182/blood-2019-123046

Published: 2019

Journal Articles

Proteasome Inhibition By Carfilzomib Impairs Terminal Erythroid Maturation and Causes Reticulocytosis in Patients with Multiple Myeloma

Nicolas Kint, MD, Elien Heylen, Kim De Keersmaecker, PhD, Catherine M. Verfaillie, MD, Michel Delforge, MDPhD

Blood (2018) 132 (Supplement 1): 1036.

https://doi.org/10.1182/blood-2018-99-110519

Published: 2018

Journal Articles

The genetics and molecular biology of T-ALL

Tiziana Girardi, Carmen Vicente, Jan Cools, Kim De Keersmaecker

Blood (2017) 129 (9): 1113–1123.

https://doi.org/10.1182/blood-2016-10-706465

Published: 2017

Journal Articles

Synergistic Targeting of Protein Translation and Inhibition of NOTCH Signaling in T-ALL

Marta Sanchez-Martin, PhD, Alberto Ambesi-Impiombato, MDPhD, Luyao Xu, Yue Qin, Daniel Herranz, PhD, Mukesh Bansal, PhD, Tiziana Girardi, Kim De Keersmaecker, Andrea Califano, PhD, Adolfo A. Ferrando, MD PhD

Blood (2015) 126 (23): 3719.

https://doi.org/10.1182/blood.V126.23.3719.3719

Published: 2015

Journal Articles

RPL5 Is a Candidate Tumor Suppressor on 1p22.1 in Multiple Myeloma of Which the Expression Is Linked to Bortezomib Response

Isabel JF Hofman, Mark van Duin, PhD, George Mulligan, PhD, Ellen Geerdens, Emanuela Garelli, Cecilia Mancini, Heidi Lemmens, Michel Delforge, Peter Vandenberghe, MDPhD, Iwona Wlodarska, Anna Aspesi, Lucienne Michaux, Pieter Sonneveld, MD PhD, Kim De Keersmaecker

Blood (2015) 126 (23): 2969.

https://doi.org/10.1182/blood.V126.23.2969.2969

Published: 2015

Journal Articles

Ribosomopathies and the paradox of cellular hypo- to hyperproliferation

Kim De Keersmaecker, Sergey O. Sulima, Jonathan D. Dinman

Blood (2015) 125 (9): 1377–1382.

https://doi.org/10.1182/blood-2014-10-569616

Published: 2015

Journal Articles

Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia

Pieter Van Vlierberghe, Alberto Ambesi-Impiombato, Kim De Keersmaecker, Michael Hadler, Elisabeth Paietta, Martin S. Tallman, Jacob M. Rowe, Carles Forne, Montserrat Rue, Adolfo A. Ferrando

Blood (2013) 122 (1): 74–82.

https://doi.org/10.1182/blood-2013-03-491092

Published: 2013

Includes: Supplemental data

Journal Articles

Therapeutic Utility of PI3Kγ Inhibition in Leukemogenesis and Tumor Cell Survival

Thomas Diacovo, MD, Dosh Whye, Evgeni Efimenko, Jianchung Chen, Valeria Tosello, PhD, Kim De Keersmaecker, PhD, Adam Kashishian, Mary Ann Thompson, MD, PhD, Mireia Castillo, MD, Carlos Cordon-Cardo, MD, PhD, Utpal P. Dave, MD, Adolfo A. Ferrando, MD, PhD, Brian J. Lannutti, PhD, Prem Subramaniam

Blood (2012) 120 (21): 1492.

https://doi.org/10.1182/blood.V120.21.1492.1492

Published: 2012

Journal Articles

An activating intragenic deletion in NOTCH1 in human T-ALL

J. Erika Haydu, Kim De Keersmaecker, Mary Kaye Duff, Elisabeth Paietta, Janis Racevskis, Peter H. Wiernik, Jacob M. Rowe, Adolfo Ferrando

Blood (2012) 119 (22): 5211–5214.

https://doi.org/10.1182/blood-2011-10-388504

Published: 2012

Journal Articles

Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia

Michaël Porcu, Maria Kleppe, Valentina Gianfelici, Ellen Geerdens, Kim De Keersmaecker, Marco Tartaglia, Robin Foà, Jean Soulier, Barbara Cauwelier, Anne Uyttebroeck, Elizabeth Macintyre, Peter Vandenberghe, Vahid Asnafi, Jan Cools

Blood (2012) 119 (19): 4476–4479.

https://doi.org/10.1182/blood-2011-09-379958

Published: 2012

Includes: Supplemental data

Journal Articles

Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL

Kim De Keersmaecker, Lucienne Michaux, André Bosly, Carlos Graux, Julio Finalet Ferreiro, Peter Vandenberghe, Jan Cools, Iwona Wlodarska

Blood (2012) 119 (16): 3864–3866.

https://doi.org/10.1182/blood-2011-10-388124

Published: 2012

Journal Articles

BCL11B Mutations In T-Cell Acute Lymphoblastic Leukemia

Blood (2010) 116 (21): 471.

https://doi.org/10.1182/blood.V116.21.471.471

Published: 2010

Journal Articles

Deletion of the Protein Tyrosine Phosphatase Gene PTPN2 in T-Cell Acute Lymphoblastic Leukemia.

Maria Kleppe, Idoya Lahortiga, PhD, Tiama El Chaar, Kim De Keersmaecker, PhD, Nicole Mentens, Carlos Graux, MD, PhD, Katrien Van Roosbroeck, Adolfo A. Ferrando, MD, PhD, Anton W Langerak, PhD, Jules P.P. Meijerink, PhD, Francois Sigaux, MD, Torsten Haferlach, MD, Iwona Wlodarska, PhD, Peter Vandenberghe, MD, PhD, Jean Soulier, MD, PhD, Jan Cools, PhD

Blood (2009) 114 (22): 141.

https://doi.org/10.1182/blood.V114.22.141.141

Published: 2009

Journal Articles

Oncogenic Transcriptional Programs Controlled by TLX1/HOX11 and TLX3/HOX11L2 in T-ALL.

Giusy Della Gatta, PhD, Teresa Palomero, PhD, Maria Luisa Sulis, MD, Xavier Solé, PhD, Wei Keat Lim, PhD, Kim De Keersmaecker, PhD, Pedro Jose Real Luna, PhD, Valeria Tosello, PhD, Fotini Gounari, PhD, Barbara Kee, PhD, Jack Lenz, PhD, Michelle Kelliher, PhD, Peter D. Aplan, MD, Jules P.P. Meijerink, PhD., Andrea Califano, PhD, Adolfo Ferrando

Blood (2009) 114 (22): 676.

https://doi.org/10.1182/blood.V114.22.676.676

Published: 2009

NARROW

HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia

Loss of the Base Excision Repair Gene Apex1 Leads to Dysfunctional Adult Hematopoietic Stem and Progenitor Cells

14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia

Opportunities of Genome Imaging for Genetic Diagnosis in Acute Lymphoblastic Leukemia

Evolution of Clinically Relevant Subclones during Chemotherapy Treatment of ALL As Determined By Single-Cell DNA and RNA Sequencing

Proteasome Inhibition By Carfilzomib Impairs Terminal Erythroid Maturation and Causes Reticulocytosis in Patients with Multiple Myeloma

The genetics and molecular biology of T-ALL

Synergistic Targeting of Protein Translation and Inhibition of NOTCH Signaling in T-ALL

RPL5 Is a Candidate Tumor Suppressor on 1p22.1 in Multiple Myeloma of Which the Expression Is Linked to Bortezomib Response

Ribosomopathies and the paradox of cellular hypo- to hyperproliferation

Whole Transcriptome Sequencing In Refractory T-Cell Acute Lymphoblastic Leukemia

Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia

Therapeutic Utility of PI3Kγ Inhibition in Leukemogenesis and Tumor Cell Survival

An activating intragenic deletion in NOTCH1 in human T-ALL

Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia

Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL

BCL11B Mutations In T-Cell Acute Lymphoblastic Leukemia

Deletion of the Protein Tyrosine Phosphatase Gene PTPN2 in T-Cell Acute Lymphoblastic Leukemia.

Oncogenic Transcriptional Programs Controlled by TLX1/HOX11 and TLX3/HOX11L2 in T-ALL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only